Description
Elsevier Advances in Oncology 2022 1st Edition by Platanias, Leonidas C.
Advances in Oncology reviews the year's most important findings and updates within the cancer field for the practicing oncologist. A distinguished editorial board, led by Dr. Leonidas C. Platanias, identifies key areas of major progress and controversy and invites preeminent specialists to contribute original articles devoted to these topics. These insightful overviews in oncology inform and enhance clinical practice by bringing concepts to a clinical level and exploring their everyday impact on patient care.Contains 27 articles on such topics as proton radiotherapy for CNS malignancies; updates on neoadjuvant therapy for resectable and borderline resectable pancreatic cancer; NTRK inhibitors in adult patients with solid tumors; and health care disparities in gynecologic cancers. Includes articles in the areas of radiation oncology, surgical oncology, medical oncology, gynecologic oncology, pediatric oncology, neuro-oncology, hematological oncology, uro-oncology, and gastrointestinal oncology. Provides in-depth, clinical reviews in oncology, providing actionable insights for clinical practice. Presents the latest information in the field under the leadership of an experienced editorial team. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews. Neoadjuvant Chemotherapy for Nonmetastatic Breast Cancer: How Response Impacts Locoregional and Adjuvant Systemic Therapy Decision MakingContemporary Multimodal Management of Primary Retroperitoneal SarcomasNTRK Inhibitors in Adult Patients with Solid TumorsThe Landscape of Personalized Medicine in Gynecologic CancerGeriatric Assessments: Tools for Every Oncologist to Stage the Aging When Caring for Older Adults with CancerSentinel Lymph Node Sampling in Endometrial CancersHealth Care Disparities in Gynecologic OncologyClinical Trials of Oncolytic Viruses in GlioblastomaCirculating Tumor Cells and Cell-free Tumor DNA in Evaluation and Management of Gliomas: Current Evidence and Potential Future Clinical UseOptimizing Hematopoietic Cellular Transplantation in Older Adults with Hematologic MalignanciesMoving Toward a Cure in Multiple Myeloma:Eradication of Measurable Residual DiseaseAdvances in Janus-Associated Kinase Inhibitor-Based Therapies for Philadelphia Chromosome-Negative Myeloproliferative NeoplasmsDeoxyribonucleic Acid Damage Response Defects: Clinical Implications and the Role of Poly-ADP Ribose Polymerase Inhibitors in Genitourinary Cancers and BeyondClinical Trial Considerations for Bladder Preservation in Muscle-Invasive Bladder CancerThe Changing Demographics of Colorectal Cancer: Rising Incidence in Younger IndividualsTotal Neoadjuvant Strategies for Locally Advanced Rectal Cancer